Opportunity Information: Apply for PA 10 164
Apply for PA 10 164
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Identification and Characterization of Molecular Targets Within the mTOR Pathway With Potential to Impact Healthspan and Lifespan (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.866 Aging Research.
- This funding opportunity was created on Apr 9, 2010 and posted on Apr 9, 2010.
- Applicants must submit their applications by May 17, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: State governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Private institutions of higher education Public housing authorities/Indian housing authorities Small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Independent school districts Native American tribal governments (Federally recognized) City or township governments Special district governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH Funding Opportunity Announcement PA 10-164, titled "Identification and Characterization of Molecular Targets Within the mTOR Pathway With Potential to Impact Healthspan and Lifespan (R21)," is a discretionary grant program designed to stimulate early-stage, high-impact research on the mTOR (mammalian target of rapamycin) signaling network. The central idea is to push forward exploratory projects that can uncover actionable molecular targets in the mTOR pathway or identify external modulators of mTOR activity, with the longer-term goal of improving human health outcomes tied to aging and cancer prevention. The opportunity is jointly aligned with two NIH institutes: the National Institute on Aging (NIA) and the National Cancer Institute (NCI), each emphasizing a slightly different, but related, set of scientific outcomes.
From the NIA perspective, the FOA prioritizes studies that identify novel molecular targets within the mTOR signaling network where intervention could plausibly extend healthspan, meaning the period of life spent in good health, functional independence, and lower burden of chronic disease. Rather than focusing only on lifespan extension as a number, the emphasis is on healthy aging outcomes in older organisms, such as preserved metabolic function, resilience to stress, improved tissue maintenance, and delay of age-associated pathologies. Applications are expected to propose credible strategies to discover or validate new nodes of control in the mTOR network, and to show how manipulating those nodes could translate into healthier aging phenotypes.
From the NCI perspective, the FOA encourages projects that identify and characterize dietary constituents that modulate the mTOR pathway in ways that support cancer prevention. This includes work aimed at pinpointing specific compounds, nutrients, or dietary-derived bioactives that influence mTOR signaling and then connecting those effects to mechanisms relevant to tumor initiation, promotion, or progression. The intent is not simply to catalog dietary factors, but to link dietary modulation of mTOR to biologically meaningful preventive mechanisms, ideally supported by mechanistic assays and models appropriate for cancer prevention research.
The announcement is deliberately broad about how applicants can pursue these goals. It explicitly supports a wide range of research approaches for both identifying targets and characterizing how they function. That can include medicinal chemistry efforts to generate or refine small molecules that interact with candidate targets, in vitro assays to probe pathway regulation and downstream effects, and experimental work in lower organisms (often used in aging biology because of speed and genetic tractability) or mammalian models where translational relevance can be tested. In practice, this flexibility is meant to encourage creative, early discovery work, including projects that may not yet be ready for a large, multi-year, fully developed research plan but have strong rationale and a clear path to generating decisive preliminary data.
The mechanism of support is the NIH Exploratory/Developmental Grant (R21), which is typically used for innovative, higher-risk concepts that need initial evidence before they can mature into larger projects. Consistent with the R21 structure, the FOA sets an award ceiling of $200,000 (as listed in the source data), and it notes that the size and duration of individual awards may vary depending on the scope and needs of the proposed research. Importantly, the FOA does not promise a fixed number of awards or a fixed total funding amount; instead, it states that the total number and value of awards will depend on factors such as the number of applications submitted, their quality, their proposed duration, and their requested budgets.
Eligibility is expansive and includes a broad mix of institutions and organizations. Eligible applicants include state, county, city/township, and special district governments; public and private institutions of higher education; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those categories where specified); for-profit organizations other than small businesses as well as small businesses; public housing authorities and Indian housing authorities; and tribal organizations, including federally recognized tribal governments and other tribal entities. The FOA also explicitly includes a wide set of additional eligible applicants such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Alaska Native and Native Hawaiian Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), U.S. territories or possessions, regional organizations, eligible federal agencies, and non-U.S. entities (foreign organizations). The opportunity does not require cost sharing or matching funds, which lowers barriers for early-stage or exploratory teams.
Administratively, the opportunity was posted and created on April 9, 2010, with an original and current closing date listed as May 17, 2013, and an archive date of June 17, 2013. The funding instrument is a grant, and the activity categories align with health and education-related research. The program is indexed under CFDA 93.866 (Aging Research) and 93.393 (Cancer Cause and Prevention Research), reflecting the two-institute focus on aging/healthspan and cancer prevention through mTOR-related biology. For applicants or readers who needed the complete announcement text during the active period, NIH provided an official link through the NIH grants guide, and technical access issues were routed to the NIH Office of Extramural Research (OER) webmaster contact.
FAQs: NIH FOA PA-10-164 (R21) - mTOR Targets for Healthspan and Lifespan
What is this funding opportunity?
This is an NIH Funding Opportunity Announcement (FOA) PA-10-164 titled "Identification and Characterization of Molecular Targets Within the mTOR Pathway With Potential to Impact Healthspan and Lifespan (R21)." It supports exploratory, early-stage research focused on the mTOR (mammalian target of rapamycin) signaling network, with the aim of identifying actionable molecular targets or external modulators of mTOR activity that could ultimately improve human health outcomes related to aging and cancer prevention.
Which NIH institutes are associated with this FOA?
The opportunity is jointly aligned with the National Institute on Aging (NIA) and the National Cancer Institute (NCI). Each institute highlights a related but distinct scientific emphasis within the broader theme of mTOR pathway biology.
What kinds of outcomes does the National Institute on Aging (NIA) emphasize?
From the NIA perspective, the FOA prioritizes studies that identify novel molecular targets within the mTOR signaling network where intervention could plausibly extend healthspan. The emphasis is on healthy aging outcomes (for example: preserved metabolic function, resilience to stress, improved tissue maintenance, and delaying age-associated pathologies), rather than focusing only on lifespan extension as a single numeric endpoint.
What kinds of outcomes does the National Cancer Institute (NCI) emphasize?
From the NCI perspective, the FOA encourages projects that identify and characterize dietary constituents that modulate the mTOR pathway in ways that support cancer prevention. This includes pinpointing specific compounds, nutrients, or dietary-derived bioactives that influence mTOR signaling and linking those effects to biologically meaningful mechanisms relevant to tumor initiation, promotion, or progression.
Is this FOA limited to one type of research approach?
No. The announcement is intentionally broad and supports a wide range of approaches for identifying targets and characterizing function. Examples mentioned include medicinal chemistry to generate or refine small molecules, in vitro assays to probe pathway regulation and downstream effects, and experimental work in lower organisms or mammalian models.
What is the overall scientific focus?
The scientific focus is on the mTOR signaling network, specifically on uncovering molecular targets within the pathway and/or identifying external modulators of mTOR activity. The longer-term intent is to advance strategies that could improve aging-related health outcomes (healthspan) and support cancer prevention.
What mechanism of support is used for this opportunity?
The FOA uses the NIH Exploratory/Developmental Grant mechanism (R21). This mechanism is typically used for innovative, higher-risk concepts that need initial evidence before they can develop into larger, more fully developed research projects.
What is the award ceiling for this R21 opportunity?
The FOA lists an award ceiling of $200,000. It also notes that the size and duration of individual awards may vary depending on the scope and needs of the proposed research.
Does the FOA guarantee a fixed number of awards or total funding amount?
No. The FOA does not promise a fixed number of awards or a fixed total funding amount. It states that the total number and value of awards depend on factors such as how many applications are submitted, the quality of those applications, their proposed duration, and the budgets requested.
Is cost sharing or matching required?
No. The opportunity does not require cost sharing or matching funds.
Who is eligible to apply?
Eligibility is broad. Eligible applicants include various government entities (state, county, city/township, and special district governments), public and private institutions of higher education, nonprofits (with and without 501(c)(3) status, as specified), for-profit organizations (including small businesses and other than small businesses), public housing authorities and Indian housing authorities, and tribal organizations (including federally recognized tribal governments and other tribal entities). The FOA also explicitly includes HBCUs, Hispanic-serving Institutions, Alaska Native and Native Hawaiian Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), U.S. territories or possessions, regional organizations, eligible federal agencies, and non-U.S. entities (foreign organizations).
Are foreign (non-U.S.) organizations eligible?
Yes. The FOA explicitly includes non-U.S. entities (foreign organizations) among eligible applicants.
What types of organizations are explicitly called out as eligible in addition to standard categories?
The FOA specifically mentions Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Alaska Native and Native Hawaiian Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), U.S. territories or possessions, regional organizations, eligible federal agencies, and foreign organizations.
What is the funding instrument?
The funding instrument is a grant.
What activity categories does this opportunity fall under?
The activity categories align with health and education-related research.
Which CFDA programs are associated with this FOA?
The FOA is indexed under CFDA 93.866 (Aging Research) and CFDA 93.393 (Cancer Cause and Prevention Research), reflecting the dual focus on aging/healthspan and cancer prevention through mTOR-related biology.
When was this opportunity posted and when did it close?
The opportunity was posted/created on April 9, 2010. The original and current closing date listed is May 17, 2013. The archive date is June 17, 2013.
Where could applicants find the official announcement text?
During the active period, NIH provided an official link through the NIH grants guide for the complete FOA text.
Who handled technical access issues related to the official FOA link?
Technical access issues were routed to the NIH Office of Extramural Research (OER) webmaster contact.
Does this FOA encourage projects that are not yet ready for a large, multi-year study?
Yes. The FOA is designed to stimulate early-stage, high-impact, exploratory work. It is positioned to support creative early discovery projects that may not yet be ready for a large, fully developed, multi-year research plan, but that have strong rationale and a clear path to generating decisive preliminary data.
Browse more opportunities from the same category: Education Health
Next opportunity: Pelvic Floor Disorders Network Data Coordinating Center (U01)
Previous opportunity: American Youth Leadership Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 10 164
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 10 164) also looked into and applied for these:
| Funding Opportunity |
|---|
| National Cancer Institute (NCI) Cancer Education and Career Development Program (R25) Apply for PAR 10 165 Funding Number: PAR 10 165 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Academic Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01) Apply for PAR 10 169 Funding Number: PAR 10 169 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Research Education Program for Clinical Researchers and Clinicians (R25) Apply for PAR 10 173 Funding Number: PAR 10 173 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| International Research Ethics Education and Curriculum Development Award (R25) Apply for PAR 10 174 Funding Number: PAR 10 174 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Apply for PAR 10 177 Funding Number: PAR 10 177 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Research Center of Excellence Grant Program (P50) Apply for PAR 10 189 Funding Number: PAR 10 189 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NLM Independent Career Development Award for Biomedical Informatics (K22) Apply for PAR 10 195 Funding Number: PAR 10 195 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Centers of Biomedical Research Excellence (COBRE) Phase III Transitional Centers P30 Apply for PAR 10 196 Funding Number: PAR 10 196 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NLM Information Resource Grants to Reduce Health Disparities (G08) Apply for RFA LM 10 001 Funding Number: RFA LM 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| OVC FY 10 Mass Casualty and Violence at Home and Abroad Conference Apply for OVC 2010 2769 Funding Number: OVC 2010 2769 Agency: Office for Victims of Crime Category: Education Health Funding Amount: $655,000 |
| NCRR Science Education Partnership Award (SEPA) (R25) Apply for PAR 10 206 Funding Number: PAR 10 206 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Biology of Manual Therapies (R01) Apply for PA 10 209 Funding Number: PA 10 209 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biology of Manual Therapies (R21) Apply for PA 10 210 Funding Number: PA 10 210 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01) Apply for PAR 10 208 Funding Number: PAR 10 208 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows In Nursing Research (F31) Apply for PAR 10 211 Funding Number: PAR 10 211 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Informed Decision Making in Young Adolescents at Risk for HIV/AIDS (R01) Apply for RFA NR 10 008 Funding Number: RFA NR 10 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| PHASE II IICOHRTA AIDS/TB Research Training Program (U2R) Apply for PAR 10 218 Funding Number: PAR 10 218 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| AIDS International Training and Research Program (AITRP) (D43) Apply for PAR 10 219 Funding Number: PAR 10 219 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Core Center of Excellence Grant Program (P30) Apply for PAR 10 220 Funding Number: PAR 10 220 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pathobiology of Emerging Pathogens in Laboratory Animals (R21) Apply for RFA RR 10 004 Funding Number: RFA RR 10 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 10 164", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
